<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB00803</drugbank-id>
  <drugbank-id>APRD00886</drugbank-id>
  <name>Colistin</name>
  <description>Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.</description>
  <cas-number>1066-17-7</cas-number>
  <unii>Z67X93HJG1</unii>
  <average-mass>1155.455</average-mass>
  <monoisotopic-mass>1154.74992728</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt;.</indication>
  <pharmacodynamics>Colistin is a polymyxin antibiotic agent. Polymyxins are cationic polypeptides that disrupt the bacterial cell membrane through a detergentlike mechanism. With the development of less toxic agents, such as extended-spectrum penicillins and cephalosporins, parenteral polymyxin use was largely abandoned, except for the treatment of multidrug-resistant pulmonary infections in patients with cystic fibrosis. More recently, however, the emergence of multidrug-resistant gram-negative bacteria, such as &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; and &lt;i&gt;Acinetobacter baumannii&lt;/i&gt;, and the lack of new antimicrobial agents have led to the revived use of the polymyxins.</pharmacodynamics>
  <mechanism-of-action>Colistin is a surface active agent which penetrates into and disrupts the bacterial cell membrane. Colistin is polycationic and has both hydrophobic and lipophilic moieties. It interacts with the bacterial cytoplasmic membrane, changing its permeability. This effect is bactericidal. There is also evidence that polymyxins enter the cell and precipitate cytoplasmic components, primarily ribosomes.</mechanism-of-action>
  <toxicity>Oral LD&lt;sub&gt;50&lt;/sub&gt; in rats is 5450 mg/kg. Overdosage with colistimethate can cause neuromuscular blockade characterized by paresthesia, lethargy, confusion, dizziness, ataxia, nystagmus, disorders of speech and apnea. Respiratory muscle paralysis may lead to apnea, respiratory arrest and death.</toxicity>
  <metabolism>As 80% of the dose can be recovered unchanged in the urine, and there is no biliary excretion, it can be assumed that the remaining drug is inactivated in the tissues, however the mechanism is unknown.</metabolism>
  <absorption>Very poor absorption from gastrointestinal tract.</absorption>
  <half-life>5 hours</half-life>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as cyclic peptides. These are compounds containing a cyclic moiety bearing a peptide backbone.</description>
    <direct-parent>Cyclic peptides</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Amino acids, peptides, and analogues</subclass>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Cyclic carboximidic acids</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Polyols</alternative-parent>
    <alternative-parent>Propargyl-type 1,3-dipolar organic compounds</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Aliphatic heteromonocyclic compound</substituent>
    <substituent>Amine</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Carboximidic acid</substituent>
    <substituent>Carboximidic acid derivative</substituent>
    <substituent>Cyclic alpha peptide</substituent>
    <substituent>Cyclic carboximidic acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic 1,3-dipolar compound</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Polyol</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Propargyl-type 1,3-dipolar organic compound</substituent>
    <substituent>Secondary alcohol</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT000691</drugbank-id>
      <name>Colistin sulfate</name>
      <unii>WP15DXU577</unii>
      <cas-number>1264-72-8</cas-number>
      <inchikey>ZJIWRHLZXQPFAD-LRYSGCCDSA-N</inchikey>
      <average-mass>1267.55</average-mass>
      <monoisotopic-mass>1266.732957062</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="english/german" coder="inn">Colistin</synonym>
    <synonym language="spanish" coder="inn">Colistina</synonym>
    <synonym language="french" coder="inn">Colistine</synonym>
    <synonym language="latin" coder="inn">Colistinum</synonym>
    <synonym language="english" coder="">Polymyxin E</synonym>
  </synonyms>
  <products>
    <product>
      <name>Coly-Mycin S</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-0399</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-11-01</started-marketing-on>
      <ended-marketing-on>2012-06-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Coly-Mycin S</name>
      <labeller>Par Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>42023-108</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-11-01</started-marketing-on>
      <ended-marketing-on>2017-06-18</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Coly-Mycin S</name>
      <labeller>Endo Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>63481-421</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-04-18</started-marketing-on>
      <ended-marketing-on>2020-04-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cortisporin TC</name>
      <labeller>Endo Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>63481-529</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-06-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cortisporin-TC</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-0564</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-05-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cortisporin-TC</name>
      <labeller>Par Pharmaceutical, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>42023-109</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Alfacolin</name>
      <company>Catalysis</company>
    </international-brand>
    <international-brand>
      <name>Alficetin</name>
      <company>Nova Argentia</company>
    </international-brand>
    <international-brand>
      <name>ColiFin</name>
      <company>Pari Pharma</company>
    </international-brand>
    <international-brand>
      <name>Colimicina</name>
      <company>Quimifar</company>
    </international-brand>
    <international-brand>
      <name>Colimycine</name>
      <company>Sanofi Aventis</company>
    </international-brand>
    <international-brand>
      <name>Coliracin</name>
      <company>Rafa</company>
    </international-brand>
    <international-brand>
      <name>Colistate</name>
      <company>Atlantic Lab</company>
    </international-brand>
    <international-brand>
      <name>Colomycin</name>
      <company>Forest</company>
    </international-brand>
    <international-brand>
      <name>Coly-Mycin</name>
      <company>King Pharmaceuticals</company>
    </international-brand>
    <international-brand>
      <name>Diarönt mono</name>
      <company>CNP</company>
    </international-brand>
    <international-brand>
      <name>Promixin</name>
      <company>Profile Pharma</company>
    </international-brand>
    <international-brand>
      <name>Tadim</name>
      <company>Allertec</company>
    </international-brand>
    <international-brand>
      <name>Walamycin</name>
      <company>Wallace</company>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Cortisporin-TC</name>
      <ingredients>Colistin + Hydrocortisone acetate + Neomycin + Thonzonium</ingredients>
    </mixture>
    <mixture>
      <name>Coly-Mycin S</name>
      <ingredients>Colistin + Hydrocortisone acetate + Neomycin + Thonzonium</ingredients>
    </mixture>
    <mixture>
      <name>Coly-Mycin S</name>
      <ingredients>Colistin + Hydrocortisone acetate + Neomycin + Thonzonium</ingredients>
    </mixture>
    <mixture>
      <name>Cortisporin-TC</name>
      <ingredients>Colistin + Hydrocortisone acetate + Neomycin + Thonzonium</ingredients>
    </mixture>
    <mixture>
      <name>Cortisporin TC</name>
      <ingredients>Colistin + Hydrocortisone acetate + Neomycin + Thonzonium</ingredients>
    </mixture>
    <mixture>
      <name>Coly-Mycin S</name>
      <ingredients>Colistin + Hydrocortisone acetate + Neomycin + Thonzonium</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Paddock Labs</name>
      <url>http://www.paddocklabs.com</url>
    </packager>
  </packagers>
  <manufacturers>
    <manufacturer generic="false" url="">Parke davis div warner lambert co</manufacturer>
  </manufacturers>
  <prices>
    <price>
      <description>Coly-Mycin S 3.3-3-10 mg/ml Suspension 5ml Bottle</description>
      <cost currency="USD">49.17</cost>
      <unit>bottle</unit>
    </price>
    <price>
      <description>Colistin sulfate powder</description>
      <cost currency="USD">513.26</cost>
      <unit>each</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Agents that produce neuromuscular block (indirect)</category>
      <mesh-id/>
    </category>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Aminoglycoside Antibacterials</category>
      <mesh-id>D000617</mesh-id>
    </category>
    <category>
      <category>Anti-Bacterial Agents</category>
      <mesh-id>D000900</mesh-id>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Antibacterials for Systemic Use</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antiinfectives for Systemic Use</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antimicrobial Cationic Peptides</category>
      <mesh-id>D023181</mesh-id>
    </category>
    <category>
      <category>Intestinal Antiinfectives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Lipids</category>
      <mesh-id>D008055</mesh-id>
    </category>
    <category>
      <category>Lipopeptides</category>
      <mesh-id>D055666</mesh-id>
    </category>
    <category>
      <category>Membrane Proteins</category>
      <mesh-id>D008565</mesh-id>
    </category>
    <category>
      <category>Nephrotoxic agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Peptides</category>
      <mesh-id>D010455</mesh-id>
    </category>
    <category>
      <category>Peptides, Cyclic</category>
      <mesh-id>D010456</mesh-id>
    </category>
    <category>
      <category>Polymyxins</category>
      <mesh-id>D011113</mesh-id>
    </category>
    <category>
      <category>Pore Forming Cytotoxic Proteins</category>
      <mesh-id>D052899</mesh-id>
    </category>
    <category>
      <category>Proteins</category>
      <mesh-id>D011506</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Gram-negative bacilli</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Suspension</form>
      <route>Auricular (otic)</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="J01XB01">
      <level code="J01XB">Polymyxins</level>
      <level code="J01X">OTHER ANTIBACTERIALS</level>
      <level code="J01">ANTIBACTERIALS FOR SYSTEMIC USE</level>
      <level code="J">ANTIINFECTIVES FOR SYSTEMIC USE</level>
    </atc-code>
    <atc-code code="A07AA10">
      <level code="A07AA">Antibiotics</level>
      <level code="A07A">INTESTINAL ANTIINFECTIVES</level>
      <level code="A07">ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>08:12.28.28</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00803.pdf?1265922751</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00695</drugbank-id>
      <name>Furosemide</name>
      <description>Furosemide may increase the ototoxic activities of Colistin.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-1.3</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-3.7</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.38e-01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-8.1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>N-[(1S)-3-amino-1-{[(1S,2R)-1-{[(1S)-3-amino-1-{[(6R,9S,12R,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl]carbamoyl}propyl]carbamoyl}-2-hydroxypropyl]carbamoyl}propyl]-5-methylheptanamide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>demeclocycline hydrochloride</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>1155.455</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>1154.74992728</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CCC(C)CCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)C(NC(=O)[C@@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C52H98N16O13</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C52H98N16O13/c1-9-29(6)11-10-12-40(71)59-32(13-19-53)47(76)68-42(31(8)70)52(81)64-35(16-22-56)44(73)63-37-18-24-58-51(80)41(30(7)69)67-48(77)36(17-23-57)61-43(72)33(14-20-54)62-49(78)38(25-27(2)3)66-50(79)39(26-28(4)5)65-45(74)34(15-21-55)60-46(37)75/h27-39,41-42,69-70H,9-26,53-57H2,1-8H3,(H,58,80)(H,59,71)(H,60,75)(H,61,72)(H,62,78)(H,63,73)(H,64,81)(H,65,74)(H,66,79)(H,67,77)(H,68,76)/t29?,30-,31-,32+,33+,34+,35+,36-,37+,38-,39?,41?,42+/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>YKQOSKADJPQZHB-BRLOSWAASA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>490.66</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>297.67</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>123.32</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>28</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>18</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>18</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>11.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>10.23</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>5.64E+005 mg/L</value>
      <source/>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>200-220 °C</value>
      <source/>
    </property>
    <property>
      <kind>logP</kind>
      <value>-2.4</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>131704173</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46505467</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C13768</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D02138</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164760862</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP001324</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Colistin</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL407135</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0004833</id>
      <name>Bacterial outer membrane</name>
      <organism>Bacteria</organism>
      <actions>
        <action>incorporation into and destabilization</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A17006</ref-id>
            <pubmed-id>20869908</pubmed-id>
            <citation>Vaara M: Polymyxins and their novel derivatives. Curr Opin Microbiol. 2010 Oct;13(5):574-81. doi: 10.1016/j.mib.2010.09.002. Epub  2010 Sep 24.</citation>
          </article>
          <article>
            <ref-id>A17007</ref-id>
            <pubmed-id>21081544</pubmed-id>
            <citation>Soon RL, Nation RL, Cockram S, Moffatt JH, Harper M, Adler B, Boyce JD, Larson I, Li J: Different surface charge of colistin-susceptible and -resistant Acinetobacter baumannii cells measured with zeta potential as a function of growth phase and colistin treatment. J Antimicrob Chemother. 2011 Jan;66(1):126-33. doi: 10.1093/jac/dkq422. Epub 2010 Nov 16.</citation>
          </article>
          <article>
            <ref-id>A17008</ref-id>
            <pubmed-id>10492501</pubmed-id>
            <citation>Evans ME, Feola DJ, Rapp RP: Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother. 1999 Sep;33(9):960-7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>yes</known-action>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>